Abstract
Effects of treatment with tobramycin initiated 1 or 24 h post-infection were investigated in a new version of a pulmonary infection model in mice. The model reflects the differentiated behaviour of Pseudomonas aeruginosa mucoid strains isolated from the lungs of one chronically infected cystic fibrosis (CF) patient at different time periods during chronic lung infection.
| Original language | English |
|---|---|
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 64 |
| Issue number | 6 |
| Pages (from-to) | 1241-50 |
| Number of pages | 10 |
| ISSN | 0305-7453 |
| DOIs | |
| Publication status | Published - 1 Dec 2009 |
Keywords
- Animals
- Anti-Bacterial Agents
- Chemokine CXCL2
- Colony Count, Microbial
- Cystic Fibrosis
- Disease Models, Animal
- Female
- Granulocyte Colony-Stimulating Factor
- Humans
- Lung
- Mice
- Mice, Inbred BALB C
- Pneumonia, Bacterial
- Pseudomonas Infections
- Pseudomonas aeruginosa
- Severity of Illness Index
- Time Factors
- Tobramycin
Fingerprint
Dive into the research topics of 'Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS